TrialBMC musculoskeletal disorders2021

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1.

Jürgen Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.